Facilitating the research of numerous nationally and internationally recognized scientists, in over sixty labs across British Columbia, to improve cancer care.

BC Cancer Research strives to improve the lives of patients through the integration of basic biomedical research, genomics, clinical trials, health services research, cancer surveillance, population health, and the development of innovative new technology, programs, and interventions. Organized through departments and programs with various themes, BC Cancer supports groundbreaking cancer research and personalized care approaches through world-class facilities and platforms including genomics, bioinformatics, imaging, drug development and tissue banking.

Our Research

The success of BC Cancer is driven by the people and their passion to reduce the impact of cancer on people and society. Our 2019 Research Report showcases how BC Cancer continues to be internationally recognized for our excellence in cancer research and its integrated model of cancer planning and care. 

Read the 2019 BC Cancer Research Report.

News & Events

December 16, 2020

Following Through: Leah Lambert pushes to improve the circle of care

Leah Lambert knows cancer care doesn’t always follow a straight line. The registered nurse with a PhD in nursing is focused on improving the patient journey and is working to erase barriers as breast cancer patients transition through their cancer care from diagnosis through to follow-up care with their primary physicians. Working as part of an interdisciplinary team on research and health systems, she has helped outline improvements in care which has led to better patient outcomes and system performance.

December 2, 2020

Fifteen BC Cancer researchers and clinicians included on Clarivate’s Highly Cited Researchers 2020 list

Fifteen BC Cancer clinicians and scientists have been named in Clarivate’s Highly Cited Researchers 2020 list announced last week. Each has been ranked in the top one per cent in their fields using a method of data and analysis performed by bibliometric experts and data scientists at the Institute for Scientific Information at Clarivate.

For BC Cancer, those fields include clinical medicine, molecular biology and genetics, and cross-field a category which recognizes influence across several fields.

Research Recovery Resources

BC Cancer Research is taking a gradual and careful approach to re-opening research activities to protect our staff, patients and communities.

Access our COVID-19 recovery resources.

Our Strategic Plan

Our Strategic Plan outlines our direction to strengthen our research capabilities and collaboration with departments and partners to improve our ability to generate knowledge, enhance the impact of our research, and support innovation in clinical care.  

Read the BC Cancer Research Strategic Plan.


Multiomics characterization of low-grade serous ovarian carcinoma identifies potential biomarkers of MEK inhibitor sensitivity and therapeutic vulnerability

Cancer Research, 2021
Raunak Shrestha, Marta Llaurado Fernandez, Amy Dawson, Joshua Hoenisch, Stanislav Volik, Yen-Yi Lin, Shawn Anderson, Hannah Kim, Anne M. Haegert, Shane Colborne, Nelson K. Y. Wong, Brian McConeghy, Robert H. Bell, Sonal Brahmbhatt, Cheng-Han Lee, Gabriel E. DiMattia, Stephane Le Bihan, Gregg B. Morin, Colin C. Collins and Mark S. Carey
Back to top